Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VISMODEGIB vs VOGLIBOSE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VISMODEGIB vs VOGLIBOSE: Safety Overview

Metric VISMODEGIB VOGLIBOSE
Total FAERS Reports 8,135 238
Deaths Reported 864 27
Death Rate 10.6% 11.3%
Hospitalizations 974 139
Average Patient Age 69.6 yrs 70.2 yrs
% Female Patients 39.3% 50.0%
FDA Approval Date Jan 30, 2012 N/A
Manufacturer Genentech, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A